TrialAIDS (London, England)2018

Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health.

Grace A McComsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.